IRIS Accounts Production v22.2.0.402 05238287 Board of Directors 1.3.21 28.2.22 28.2.22 false true false false false true false Fair value model Ordinary 0.010 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure052382872021-02-28052382872022-02-28052382872021-03-012022-02-28052382872020-02-29052382872020-03-012021-02-28052382872021-02-2805238287ns16:EnglandWales2021-03-012022-02-2805238287ns15:PoundSterling2021-03-012022-02-2805238287ns11:Director12021-03-012022-02-2805238287ns11:PrivateLimitedCompanyLtd2021-03-012022-02-2805238287ns11:SmallEntities2021-03-012022-02-2805238287ns11:AuditExempt-NoAccountantsReport2021-03-012022-02-2805238287ns11:SmallCompaniesRegimeForDirectorsReport2021-03-012022-02-2805238287ns11:SmallCompaniesRegimeForAccounts2021-03-012022-02-2805238287ns11:AbridgedAccounts2021-03-012022-02-280523828712021-03-012022-02-2805238287ns11:OrdinaryShareClass12021-03-012022-02-2805238287ns11:Director22021-03-012022-02-2805238287ns11:CompanySecretary12021-03-012022-02-2805238287ns11:RegisteredOffice2021-03-012022-02-2805238287ns6:CurrentFinancialInstruments2022-02-2805238287ns6:CurrentFinancialInstruments2021-02-2805238287ns6:Non-currentFinancialInstruments2022-02-2805238287ns6:Non-currentFinancialInstruments2021-02-2805238287ns6:ShareCapital2022-02-2805238287ns6:ShareCapital2021-02-2805238287ns6:FurtherSpecificReserve3ComponentTotalEquity2022-02-2805238287ns6:FurtherSpecificReserve3ComponentTotalEquity2021-02-2805238287ns6:RetainedEarningsAccumulatedLosses2022-02-2805238287ns6:RetainedEarningsAccumulatedLosses2021-02-2805238287ns6:NetGoodwill2021-03-012022-02-2805238287ns6:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2805238287ns6:PatentsTrademarksLicencesConcessionsSimilar2021-03-012022-02-2805238287ns6:OwnedOrFreeholdAssetsns6:LandBuildings2021-03-012022-02-2805238287ns6:FurnitureFittings2021-03-012022-02-2805238287ns6:MotorVehicles2021-03-012022-02-2805238287ns6:ComputerEquipment2021-03-012022-02-2805238287ns6:Secured2022-02-2805238287ns6:Secured2021-02-2805238287ns11:OrdinaryShareClass12022-02-2805238287ns6:FurtherSpecificReserve3ComponentTotalEquity2021-02-28
REGISTERED NUMBER: 05238287 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2022

for

C & P Apothecaries Limited

C & P Apothecaries Limited (Registered number: 05238287)






Contents of the Financial Statements
for the Year Ended 28 February 2022




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


C & P Apothecaries Limited

Company Information
for the Year Ended 28 February 2022







DIRECTORS: P P J Higgins
C J McKeating





SECRETARY: P P J Higgins





REGISTERED OFFICE: 61 Rodney Street
Liverpool
Merseyside
L1 9ER





REGISTERED NUMBER: 05238287 (England and Wales)





ACCOUNTANTS: Alexander Myerson & Co Limited
Alexander House
61 Rodney Street
Liverpool
Merseyside
L1 9ER

C & P Apothecaries Limited (Registered number: 05238287)

Abridged Balance Sheet
28 February 2022

28.2.22 28.2.21
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 108,005 444,379
Tangible assets 5 280,129 320,873
Investments 6 100 100
Investment property 7 245,000 245,000
633,234 1,010,352

CURRENT ASSETS
Stocks 100,537 133,958
Debtors 1,330,890 1,342,951
Cash at bank and in hand 321,441 536,232
1,752,868 2,013,141
CREDITORS
Amounts falling due within one year 1,186,825 1,170,267
NET CURRENT ASSETS 566,043 842,874
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,199,277

1,853,226

CREDITORS
Amounts falling due after more than one
year

-

(1,198,497

)

PROVISIONS FOR LIABILITIES (12,604 ) (15,634 )
NET ASSETS 1,186,673 639,095

CAPITAL AND RESERVES
Called up share capital 9 10 10
Fair value reserve 10 (96,170 ) (96,170 )
Retained earnings 1,282,833 735,255
SHAREHOLDERS' FUNDS 1,186,673 639,095

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

C & P Apothecaries Limited (Registered number: 05238287)

Abridged Balance Sheet - continued
28 February 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 28 February 2022 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 September 2022 and were signed on its behalf by:





C J McKeating - Director


C & P Apothecaries Limited (Registered number: 05238287)

Notes to the Financial Statements
for the Year Ended 28 February 2022

1. STATUTORY INFORMATION

C & P Apothecaries Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents the total invoice value, excluding value added tax, of sales made during the financial year and derives from the provision of goods falling within the company's ordinary activities.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of businesses, is being amortised evenly over its estimated useful life of 20 years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Lease are being amortised evenly over their estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 4% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


C & P Apothecaries Limited (Registered number: 05238287)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2022

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2021 - 26 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2021 1,389,085
Disposals (840,000 )
At 28 February 2022 549,085
AMORTISATION
At 1 March 2021 944,706
Amortisation for year 44,954
Eliminated on disposal (548,580 )
At 28 February 2022 441,080
NET BOOK VALUE

At 28 February 2022 108,005
At 28 February 2021 444,379

C & P Apothecaries Limited (Registered number: 05238287)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2022

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2021 809,258
Disposals (108,000 )
At 28 February 2022 701,258
DEPRECIATION
At 1 March 2021 488,385
Charge for year 30,244
Eliminated on disposal (97,500 )
At 28 February 2022 421,129
NET BOOK VALUE
At 28 February 2022 280,129
At 28 February 2021 320,873

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals
£   
COST
At 1 March 2021 30,000
Transfer to ownership (30,000 )
At 28 February 2022 -
DEPRECIATION
At 1 March 2021 19,533
Transfer to ownership (19,533 )
At 28 February 2022 -
NET BOOK VALUE
At 28 February 2022 -
At 28 February 2021 10,467

6. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 March 2021
and 28 February 2022 100
NET BOOK VALUE
At 28 February 2022 100
At 28 February 2021 100

C & P Apothecaries Limited (Registered number: 05238287)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2022

7. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 March 2021
and 28 February 2022 245,000
NET BOOK VALUE
At 28 February 2022 245,000
At 28 February 2021 245,000

Fair value at 28 February 2022 is represented by:
£   
Valuation in 2021 (142,720 )
Cost 387,720
245,000

8. SECURED DEBTS

The following secured debts are included within creditors:

28.2.22 28.2.21
£    £   
Bank loans 273,302 1,331,014

National Westminster Bank has a fixed and floating charge, dated 28th October 2015, over all property and undertakings of the company

9. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 28.2.22 28.2.21
value: £    £   
100,000 Share capital 1 0.000 1p 10 10

10. RESERVES
Fair
value
reserve
£   
At 1 March 2021
and 28 February 2022 (96,170 )